The dried roots of Stemona sessilifolia (MIQ.) MIQ., S. japonica (BL.) MIQ., and S. tuberosa LOUR. are the genuine sources of Stemonae Radix described in the Chinese Pharmacopoeia for antitussive and insecticidal remedy. 1) Chemical studies show that the Stemona alkaloids, which exist only in the Stemonaceae family, are major components responsible for antitussive actions.
In order to distinguish the three medical Stemona species from each other, and from the relevant species S. parviflora as well as the counterfeit of Stemonae Radix, Asparagus cochinchinensis (LOUR.) MERR., in genetic level, we determined their DNA sequence of chloroplast trnL-trnF, petBpetD, trnK-rps16 and trnH-psbA regions in the previous research and found that the nucleotide differences in the four regions provided molecular markers for authentication. 10) Based on the sequence differences, we further analyzed the restriction map of each sequence. The results showed that restriction enzymes MwoI, AciI and XmnI were able to recognize specific sequence sites in the trnL-trnF region, while BclI, HincII and BslI could recognize specific sequence sites in the petB-petD region, allowing the four Stemona species to be discriminated from each other and from the counterfeits. Therefore, the present study aims to set up polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods for the discrimination of the sources of Stemonae Radix effectively and efficiently. (Tables 1, 2) were used. The plant specimens were identified by the authors. Vouchers are stored at Herbarium of Pharmacognosy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China and the Museum of Materia Medica, Institute of Natural Medicine, University of Toyama, Japan.
MATERIALS AND METHODS

Materials
Total DNA was extracted from leaf or crude drugs using the DNeasy TM Plant Mini Kit (QIAGEN, Germany) with several modifications to the protocol provided by manufacturer, i.e., the incubation time at 65°C was extended to 4 h from 10 min, and the incubation time on ice was extended to 1 h from 5 min.
PCR Amplification PCR was conducted using two pairs of primers for the trnL-trnF region [trnLF-167F (GAA TGG AGT TGA TTG CGT TA) and trnLF-374R (TTC GAT TTC GAT TGA AGT GA); trnLF-680F (TCT TTC ATA AAT AGA TCC GAA CA) and trnLF-993R (ACT GAG CTA TCC CGA CCC TT)], and one pair of primers for the petBpetD region [PIpetB-F (CTG CCG TAT TTA TGT TAA TG) and petD585R (GTC TAG CCC CTG TTC TTC CT)]. A 30 ml PCR mixture contained 1 mg/ml bovine serum albumin (BSA), 0.2 mM of each dNTP, 0.25 mM of each primer, 1ϫPCR buffer and 1.5 U Taq polymerase (NIPPON GENE Co., Ltd., Japan) and 0.5 ml of total DNA as template. The PCR amplification was performed using a Takara thermal cycler (Takara, Japan), and the cycling program included one cycle of 95°C for 5 min; then 35 cycles of 95°C for 30 s, 52°C for 30 s (for trnL-trnF region) or 50°C for 30 s (for petB-petD region) and 72°C for 50 s; and a final extension at 72°C for 7 min. RFLP Analysis Restriction maps of the chloroplast trnL-trnF and petB-petD sequences from S. sessilifolia, S. japonica, S. tuberosa, S. parviflora and A. cochinchinensis were constructed using the program Mikenora Research (Daiichi Pure Chemicals Co., Ltd., Japan). Thereafter, restriction enzymes MwoI, AciI and XmnI for trnL-trnF region, and BclI, HincII and BslI for petB-petD region were selected to discriminate the four Stemona species from each other and from the counterfeits.
Identification of the Botanical Source of Stemonae Radix Based on Polymerase Chain Reaction with Specific Primers and Polymerase Chain Reaction-Restriction Fragment Length Polymorphism
Fitting volume of the resulting PCR products from all specimens were digested with 10 U of the enzyme to the final reaction system of 20 ml for 4 h, respectively. The PCR products of trnL-trnF were digested with MwoI, AciI and XmnI (New England Biolabs, U.K.), while those of petB-petD were digested with HincII (TaKaRa, Japan), BclI and BslI (New England Biolabs, U.K.). The resulting restriction digests were separated by a 2.5% agarose gel electrophoresis and visualized by staining with GelRed TM Nucleic Acid Gel Stain (Wako Chemicals, Japan).
RESULTS AND DISCUSSION
The restriction maps of trnL-trnF region (Fig. 1a) showed that MwoI can recognize the 11-bp sequence (GCAAAA-A Taking into account the fact that it is difficult to amplify long DNA fragment due to the degeneration of genomic DNA during the preparation or storage of crude drugs, we designed the primers for amplification of short regions at first. Two species-specific primer pairs (trnLF-167F and trnLF-374R, trnLF-680F and trnLF-993R in Fig. 1a) were synthesized to amplify two fragments (about 300 bp and 200 bp, respectively) in the trnL-trnF region from Stemona species. However, the counterfeits cannot be amplified to obtain clear fragments with the same length. One primer pair (PIpetB-F and petD585R in Fig. 1b ) was synthesized to amplify a single fragment (about 650 bp) in the petB-petD region from all samples.
Thirteen leaf samples from the four Stemona species above and one A. cochinchinensis formerly sequenced were used to verify the designed PCR-RFLP method. The expected fragment sizes resulted from restriction enzyme digestion were shown in Table 3 . The digestion patterns of PCR products of trnL-trnF and petB-petD regions (Figs. 2a, b) were consistent with our expectation. For example, a MwoI recognition site existed only in trnL-trnF sequence of S. japonica (Fig. 1a) , therefore, digestion of the PCR products of this region by MwoI resulted in the 195 bp PCR product (Lane 1 in Fig. 2a ) of S. japonica was cleaved into two fragments of 104 bp and 91 bp (the two appeared as only one band due to limited resolution of agarose electrophoresis), enabling rapid discrimination of S. japonica from the others (Lane A1 in Fig. 2a) . By the developed methods, eleven commercial samples from various places of China were identified. Figure 3 showed the results of PCR-RFLP analysis of crude drugs by using restriction enzyme BslI to digest partial fragment of chloroplast petB-petD region. Of 11 crude drug samples, nine were identified to be derived from S. tuberosa, and the other 2 were counterfeits derived from Asparagus spp. (Table  2 ). This suggests that the major source of Stemonae Radix is S. tuberosa in markets, even in the distribution areas of S. sessilifolia and S. japonica. Since the accurate identification of the herbal drugs is a prerequisite for clinical use and pharmacological research, the methods described in this study must be useful for the quality control of Stemonae Radix. Table 2 of each crude drug. M: 1 kb plus DNA ladder.
